GENE ONLINE|News &
Opinion
Blog

Feature
Novavax to Deliver 100 Million COVID-19 Vaccine Doses by January 2021
2020-07-12
Regeneron Secures $4.5 Billion Worth of Contracts from the US for Combating COVID-19
2020-07-10
Solutions, Challenges, and Opportunities in Pandemic
2020-07-08Partner
Pfizer and BioNTech’s COVID-19 Vaccine Shows Encouraging Results
2020-07-05
Spotlight: Roche’s SMA Drug, Risdiplam Makes Strong Case for Regulatory Approval
2020-07-05
COVAXIN- India’s First Indigenous Vaccine Approved for Human Trials
2020-07-02
Verve Therapeutic’s One Time Base Editing Treatment Cuts Down Cholesterol Levels in Blood
2020-06-30
Proximity RNA Sequencing: Breaking New Grounds in Spatial Transcriptomics
2020-06-28
COVID-19: Discovery of New Spike Protein Neutralizing Antibody Reveals Promising Drug Target
2020-06-28
Eli Lilly Launches Phase 3 Trial with Baricitinib for COVID-19 Patients
2020-06-26
Early Kidney Cancer Detection Made Possible with a Simple Blood Test
2020-06-25
BIO Digital 2020 Highlights: Global Solutions for Implementation: From Scale-up to Worldwide Access
2020-06-24
BIO Digital 2020 Highlights: How COVID-19 Will Radically Change Biomedical R&D Across the Globe?
2020-06-21
BIO Digital 2020 Highlights: Leveraging Platforms and Partnerships to Develop COVID-19 Vaccines in Record Time
2020-06-21
Dexamethasone Renews Hopes for a Life Saving COVID-19 Treatment
2020-06-20
1 49 50 51 52 53 60
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top